I'll attempt to answer this.
Think of it this way... What is the difference between having 1 syringe of each and injecting each medication separately, vs. combining them into the same syringe. Nothing. What is important is calculating the units correctly for J3301 and J9910 based on the concentrations, total volume administered. This where your high-school math and algebra comes into play. (Remember in high school when you swore you'd never use or need algebra?)
So you can bill J3301 and J9910 separately in correct units (after your math homework has been completed).
It's possible that after math, the J3301 will be a fraction of a unit, (since you are diluting 9:1) and you'd just round up to 1 unit. And calculate the same for the F-5U
As backup for my claim, according to Noridian, this doesn't meet the definition of a compounded drug
https://med.noridianmedicare.com/web/jeb/topics/drugs-biologicals-injections
"Mixing two or more pre-packaged products in the same syringe when prepared according to label instructions, does not meet the definition of a compounded drug."
Therefor, i'd conclude that you have to bill the J-codes individually.
Which procedure code to use?
For injecting scars, use 11900/11901 for Kenalog. CPT 96405 is typically used for injecting scars with 5-FU. But you can't code both codes. Pick one. You'd have a good defense with 96405 since 90% of the medicine being injected is 5-FU.
Even though 11900/96405 is based on lesion count, if the scar is large enough and you have to inject several sites on the same scar, you can count those as separate injections (i.e.lesions). Document CLEARLY the size of the scar being injected (dimensions) to cover your behind in an audit and I'd include wording that stated "due to the size of the fibrous tissue, it required injections at multiple sites/locations. Even photo or drawing showing the lesion and marks approximating the injection sites would help.